Atea Pharmaceuticals Ownership | Who Owns Atea Pharmaceuticals?

Overview ForecastFinancials Chart Transcripts

Atea Pharmaceuticals Ownership Summary

Atea Pharmaceuticals is owned by 43.83% institutional investors, 13.61% insiders, and 42.56% retail investors. Blackrock is the largest institutional shareholder, holding 10.87% of AVIR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 7.38% of its assets in Atea Pharmaceuticals shares.

AVIR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Atea Pharmaceuticals	43.83%	13.61%	42.56%
Sector	Healthcare Stocks	232.63%	10.66%	-143.29%
Industry	Biotech Stocks	382.12%	10.42%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	9.12M	10.87%	$30.19M
Blackrock funding, inc. /de	8.49M	10.74%	$30.31M
Bml capital management	7.49M	9.47%	$26.74M
Fmr	5.82M	6.95%	$16.89M
Tang capital management	4.83M	5.76%	$14.00M
Vanguard group	4.23M	5.35%	$15.09M
Bain capital life sciences investors	2.49M	2.97%	$7.21M
Geode capital management	1.84M	2.33%	$6.57M
State street	1.78M	2.13%	$5.17M
Dimensional fund advisors lp	1.37M	1.74%	$4.90M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bml capital management	7.49M	23.11%	$26.74M
Peapod lane capital	435.02K	1.32%	$1.55M
Cm management	355.00K	1.07%	$1.27M
Tang capital management	4.83M	0.54%	$14.00M
Bain capital life sciences investors	2.49M	0.48%	$7.21M
Aldebaran capital	90.53K	0.29%	$323.19K
Auour investments	177.00K	0.20%	$631.89K
Rangeley capital	80.00K	0.20%	$232.00K
Newtyn management	492.28K	0.17%	$1.43M
Nano cap new millennium growth fund l p	50.00K	0.15%	$178.50M

Top Buyers

Holder	Shares	% Assets	Change
Jpmorgan chase	1.35M	0.00%	731.44K
Acadian asset management	1.30M	0.01%	334.13K
Royal bank of canada	301.88K	0.00%	289.65K
Morgan stanley	656.08K	0.00%	205.51K
Goldman sachs group	472.52K	0.00%	132.38K

Top Sellers

Holder	Shares	% Assets	Change
Ecor1 capital	-	-	-3.34M
Vanguard group	4.23M	0.00%	-482.17K
Almitas capital	-	-	-445.39K
Acuitas investments	-	-	-323.54K
Dimensional fund advisors lp	1.37M	0.00%	-166.77K

New Positions

Holder	Shares	% Assets	Change	Value
Aldebaran capital	90.53K	0.29%	90.53K	$323.19K
Cubist systematic strategies	87.77K	0.00%	87.77K	$254.54K
Nano cap new millennium growth fund l p	50.00K	0.15%	50.00K	$178.50M
Millennium management	22.51K	-	22.51K	$75.39K
Rfg advisory	14.88K	0.00%	14.88K	$53.10K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-15.00
Federation des caisses desjardins du quebec	-24.00
Capital performance advisors llp	-31.00
Smartleaf asset management	-46.00
Colonial trust advisors	-46.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	73	-37.61%	34,651,553	-34.79%	43	1.09%	24	-45.45%	29	-27.50%
Sep 30, 2025	113	7.62%	52,737,533	0.09%	62	1.59%	41	-16.33%	40	53.85%
Jun 30, 2025	104	-	52,674,204	0.85%	62	1.67%	49	11.36%	25	-32.43%
Mar 31, 2025	104	-2.80%	52,838,521	-6.02%	62	1.40%	45	-15.09%	38	22.58%
Dec 31, 2024	105	-2.78%	56,185,130	-2.97%	66	1.41%	52	-1.89%	30	3.45%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	5.77M	7.38%	311.10K
Fidelity Growth Compy Commingled Pl O	3.73M	4.42%	23.40K
Vanguard Total Stock Mkt Idx Inv	2.37M	3.03%	-
Vanguard US Total Market Shares ETF	2.36M	2.76%	-
Fidelity Growth Company Fund	2.12M	2.71%	142.79K
iShares Russell 2000 ETF	1.72M	2.21%	120.87K
Fidelity Growth Company K6	1.05M	1.34%	50.85K
Fidelity Small Cap Index	764.27K	0.98%	-909.00
Vanguard Institutional Extnd Mkt Idx Tr	741.08K	0.95%	-
BlackRock Advantage Small Cap Core Instl	620.97K	0.79%	-14.57K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 16, 2025	BERGER FRANKLIN M	-	Buy	$33.61K
Jan 15, 2025	BERGER FRANKLIN M	-	Buy	$47.88K
Jan 16, 2025	BERGER FRANKLIN M	-	Sell	$33.61K
Jan 15, 2025	BERGER FRANKLIN M	-	Sell	$47.88K
Dec 10, 2024	BERGER FRANKLIN M	-	Sell	$1.02M

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q2	-	-
2025 Q1	4	-
2024 Q4	-	1
2024 Q3	-	3

AVIR Ownership FAQ

Who Owns Atea Pharmaceuticals?

Atea Pharmaceuticals shareholders are primarily institutional investors at 43.83%, followed by 13.61% insiders and 42.56% retail investors. The average institutional ownership in Atea Pharmaceuticals's industry, Biotech Stocks , is 382.12%, which Atea Pharmaceuticals falls below.

Who owns the most shares of Atea Pharmaceuticals?

Atea Pharmaceuticals’s largest shareholders are Blackrock (9.12M shares, 10.87%), Blackrock funding, inc. /de (8.49M shares, 10.74%), and Bml capital management (7.49M shares, 9.47%). Together, they hold 31.08% of Atea Pharmaceuticals’s total shares outstanding.

Does Blackrock own Atea Pharmaceuticals?

Yes, BlackRock owns 10.87% of Atea Pharmaceuticals, totaling 9.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.19M$. In the last quarter, BlackRock decreased its holdings by -123K shares, a -1.33% change.

Who is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 23.11% of its assets in 7.49M Atea Pharmaceuticals shares, valued at 26.74M$.

Who is the top mutual fund holder of Atea Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Atea Pharmaceuticals shares, with 7.38% of its total shares outstanding invested in 5.77M Atea Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools